1-4 of 4
blood platelet disorders
Close
Sort by
Journal Articles

Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation

Michelle C. Krutein, Matthew R. Hart, Donovan J. Anderson, Jasmin Jeffery, Andriana G. Kotini, Jin Dai, Sylvia Chien, Michaela DelPriore, Sara Borst, Jean Ann Maguire, Deborah L. French, Paul Gadue, Eirini P. Papapetrou, Siobán B. Keel, Pamela S. Becker, Marshall S. Horwitz
Journal: Blood Advances
Blood Adv (2021) 5 (3): 687–699.
https://doi.org/10.1182/bloodadvances.2020002709
Published: 2021
Includes: Supplemental data
Journal Articles

Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients

Paul Vulliamy, Samantha J. Montague, Scarlett Gillespie, Melissa V. Chan, Lucy A. Coupland, Robert K. Andrews, Timothy D. Warner, Elizabeth E. Gardiner, Karim Brohi, Paul C. Armstrong
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2623–2630.
https://doi.org/10.1182/bloodadvances.2020001776
Published: 2020
Includes: Supplemental data
Journal Articles

Bye AP, Unsworth AJ, Desborough MJ, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv. 2017;1(26):2610-2623.

Journal: Blood Advances
Blood Adv (2018) 2 (23): 3515.
https://doi.org/10.1182/bloodadvances.2018028944
Published: 2018
Journal Articles

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib

Clinical Trials & Observations
Alexander P. Bye, Amanda J. Unsworth, Michael J. Desborough, Catherine A. T. Hildyard, Niamh Appleby, David Bruce, Neline Kriek, Sophie H. Nock, Tanya Sage, Craig E. Hughes, Jonathan M. Gibbins
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2610–2623.
https://doi.org/10.1182/bloodadvances.2017011999
Published: 2017
Includes: Multimedia, Supplemental data